Rankings
▼
Calendar
IOBT Q4 2020 Earnings — IO Biotech, Inc. Revenue & Financial Results | Market Cap Arena
IOBT
IO Biotech, Inc.
$18M
Q4 2020 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$3M
Net Income
-$3M
EPS (Diluted)
$-0.22
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$3M
Free Cash Flow
-$3M
Stock-Based Comp.
$16,000
Balance Sheet
Total Assets
$6M
Total Liabilities
$3M
Stockholders' Equity
$3M
Cash & Equivalents
$3M
← FY 2020
All Quarters
Q1 2021 →
